WHO says Sinopharm prevents Omicron admissions to hospital
Covid-19 vaccines produced by China's Sinopharm and Sinovac can offer protection against severe illness, admission to hospital and death related to the Omicron variant, a World Health Organisation official said
Updated: January 05, 2022, 12:15 PM